CliffBio
small molecule

SULFANILAMIDE

SULFANILAMIDE

Loss of exclusivity—loss of exclusivity
CompanyCosette Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameSULFANILAMIDE
Active ingredientSULFANILAMIDE
Strength15%
Dosage formCREAM
RouteVAGINAL
ModalitySmall molecule
FDA approvalSeptember 1985
Marketing statusDISCN

More from Cosette Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.